Phase 3 Registry Listing Describes CBL-514 Study for Abdominal Subcutaneous Fat
A ClinicalTrials.gov listing describes a Phase 3 trial of CBL-514 injection for abdominal subcutaneous fat, using a randomized, double-blinded, placebo-controlled design.